Association of Wnt1/β-catenin with clinical pathological characteristics and prognosis of esophageal squamous cell carcinoma

Genetic Testing and Molecular Biomarkers

Volumn 14, Issue 3, 2010, Pages 363-369

  Lv, Jin ^a   Cao, Xiu Feng ^a   Ji, Lv ^a   Zhu, Bin ^a   Tao, Lei ^a   Wang, Dong Dong ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; MESSENGER RNA; WNT1 PROTEIN; TUMOR MARKER; WNT1 PROTEIN, HUMAN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER SURVIVAL; CANCER TISSUE; CLINICAL FEATURE; CONTROLLED STUDY; DOWN REGULATION; ESOPHAGUS CARCINOMA; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; UPREGULATION; CANCER STAGING; ESOPHAGUS TUMOR; GENETICS; LYMPH NODE; METABOLISM; MIDDLE AGED; PATHOLOGY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BETA CATENIN; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL; WNT1 PROTEIN;

EID: 77954919297     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2009.0173     Document Type: Article

References (31)

1. Barker N, Clevers H (2006) Mining the Wnt pathway for cancer therapeutics. Nat Rev Drug Discov 5:997-1014.
2. Chan SL, Cui Y, van Hasselt A, et al. (2007) The tumor suppressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomas. Lab Invest 87:644-650.
3. Clifford RL, Deacon K, Knox AJ (2008) Novel regulation of vascular endothelial growth factor-A (VEGF-A) by transforming growth factor (beta)1: requirement for Smads, (beta)-catenin, and GSK3(beta). J Biol Chem 283:35337-35353.
4. Corrigan PM, Dobbin E, Freeburn RW, Wheadon H (2009) Patterns of Wnt/Fzd/LRP gene expression during embryonic hematopoiesis. Stem Cells Dev 18:759-772.
5. Dihlmann S, von Knebel Doeberitz M (2005) Wnt/b-catenin-pathway as a molecular target for future anti-cancer therapeutics. Int J Cancer 113:515-524.
6. Egashira M, Naruke Y, Kondo H, et al. (2009) Im-munohistochemical analyses of beta-catenin and cyclin D1 expression in giant cell tumor of bone (GCTB): a possible role of Wnt pathway in GCTB tumorigenesis. Pathol Res Pract 205:626-633.
7. Fillmore RA, Mitra A, Xi Y, et al. (2009) Nmi (N-Myc interactor) inhibits Wnt/beta-catenin signaling and retards tumor growth. Int J Cancer 125:556-564.
8. Greene FL (2002) American Joint Committee on Cancer, American Cancer Society. AJCC Cancer Staging Manual. 6th edition. Springer, New York, pp 91-98.
9. Herbst A, Kolligs FT (2007) Wnt signaling as a therapeutic target for cancer. Methods Mol Biol 361:63-91.
10. Huang M, Wang Y, Sun D, et al. (2006) Identification of genes regulated by Wnt/b-catenin pathway and involved in apo-ptosis via microarray analysis. BMC Cancer 6:220-231.
11. Ji L, Cao XF, Wang HM, et al. (2007) Expression level of beta-catenin is associated with prognosis of esophageal carcinoma. World J Gastroenterol 13:2622-2625.
12. Katoh M, Katoh M (2007) WNT signaling pathway and stem cell signaling network. Clin Cancer Res 13:4042-4045.
13. Krishnadath KK, Tilanus HW, van Blankenstein M, et al. (1997) Reduced expression of the cadherin-catenin complex in oeso-phageal adenocarcinoma correlates with poor prognosis. J Pathol 182:331-338.
14. Logan, CY, Nusse R (2004) The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20:781-810.
15. Lo Muzio L, Pannone G, Staibano S, et al. (2002) WNT-1 expression in basal cell carcinoma of head and neck. An immunohis-tochemical and confocal study with regard to the intracellular distribution of beta-catenin. Anticancer Res 22:565-576.
16. Lu W, Tinsley HN, Keeton A, et al. (2009) Suppression of Wnt/b-catenin signaling inhibits prostate cancer cell proliferation. Eur J Pharmacol 602:8-14.
17. Lyu J, Yamamoto V, Lu W (2008) Cleavage of the Wnt receptor Ryk regulates neuronal differentiation during cortical neuro-genesis. Dev Cell 15:773-780.
18. James RG, Conrad WH, Moon RT (2008) Beta-catenin-independent Wnt pathways: signals, core proteins, and effectors. Methods Mol Biol 468:131-144.
19. Matsubayashi S, Nakashima M, Kumagai K, et al. (2009) Immunohistochemical analyses of beta-catenin and cyclin D1 expression in giant cell tumor of bone (GCTB): a possible role of Wnt pathway in GCTB tumorigenesis. Pathol Res Pract 205:626-633.
20. Mizushima T, Nakagawa H, Kamberov YG, et al. (2002) Wnt-1 but not epidermal growth factor induces b-catenin/T-cell factor-dependent transcription in esophageal cancer cells. Cancer Res 62:277-282.
21. Moon RT, Kohn AD, De Ferrari GV, Kaykas A (2004) WNT and beta-catenin signalling: diseases and therapies. Nat Rev Genet 5:691-701.
22. Nakanishi Y, Ochiai A, Akimoto S, et al. (1997) Expression of E-cadherin, apha-catenin, beta-catenin and plakoglobin in eso-phageal carcinomas and its prognostic significance: immuno-histochemical analysis of 96 lesions. Oncology 54:158-165.
23. Nakashima T, Liu D, Nakano J, et al. (2008) Wnt1 overexpression associated with tumor proliferation and a poor prognosis in non-small cell lung cancer patients. Oncol Rep 19:203-209.
24. Nusse R (2005) Wnt signaling in disease and in development. Cell Res 15:28-32.
25. Osterheld MC, Bian YS, Bosman FT, et al. (2002) Beta-catenin expression and its association with prognostic factors in adenocarcinoma developed in Barrett esophagus. Am J Clin Pathol 117:451-455.
26. Paul S, Dey A (2008) Wnt signaling and cancer development: therapeutic implication. Neoplasma 55:165-176.
27. Tian X, Du H, Fu X, et al. (2009) Smad4 restoration leads to a suppression of Wnt/beta-catenin signaling activity and migration capacity in human colon carcinoma cells. Biochem Biophys Res Commun 380:478-483.
28. Verkaar F, van Rosmalen JW, Smits JF, et al. (2009) Stably overexpressed human Frizzled-2 signals through the beta-catenin pathway and does not activate Ca2\+-mobilization in Human Embryonic Kidney 293 cells. Cell Signal 21:22-33.
29. Wieczorek M, Paczkowska A, Guzenda P, et al. (2008) Silencing of Wnt-1 by siRNA induces apoptosis of MCF-7 human breast cancer cells. Cancer Biol Ther 7:268-274.
30. Winkel A, Stricker S, Tylzanowski P, et al. (2008) Wnt-ligand-dependent interaction of TAK1 (TGF-beta-activated kinase-1) with the receptor tyrosine kinase Ror2 modulates canonical Wnt-signalling. Cell Signal 20:2134-2144.
31. Zhang H, Xue Y (2008) Wnt pathway is involved in advanced gastric carcinoma. Hepatogastroenterology 55:1126-1130.